Digoxin
Report in 0 hours
Booked 3 times
Digoxin

Navigating Cardiac Wellness through Precision Monitoring of Digoxin Levels

The Ibn Sina Trust
Praava Health
Dr Lal PathLabs
Omnicare Diagnostic Limited
Thyrocare Bangladesh Ltd
Brac Healthcare
Popular Diagnostic Centre Ltd
JG Healthcare
Sample Type
blood
Fasting Required
No
Description

The Digoxin test measures the concentration of digoxin, a cardiac glycoside used to treat heart conditions like atrial fibrillation and heart failure. Monitoring levels is crucial because both underdosing and overdosing can lead to serious complications.

Covid Safety

Assured

Free Report

Counselling

How our test process works!

Step 1

Sample Collection

Vaccinated Phlebotomists collects from syringe in the barcoded vials

Step 2

Sample Storage

Only vaccinated phelbos are assigned orders

Step 3

High Tech Facility

Lab ingests the sample into processing machines which are 100% automated

Step 4

Accurate Digital Reports

The reports are generated by the processing machines and clinically correlated by doctors

Overview

The digoxin test measures the level of digoxin, a medication commonly used to treat heart conditions such as atrial fibrillation and heart failure, in the blood. Here's a brief overview:

Purpose

  • Monitor Digoxin Levels: Ensures that the drug concentration is within the therapeutic range, avoiding toxicity or ineffectiveness.
  • Evaluate Treatment Efficacy: Helps assess how well the patient is responding to digoxin therapy.

Procedure

  • Sample Collection: A blood sample is taken, usually from a vein in the arm.
  • Timing: It's often recommended to test levels after the drug has reached a steady state (typically 6-8 hours after a dose).

Therapeutic Range

  • Normal Levels: Typically between 0.5 to 2.0 ng/mL, but the exact range can vary based on clinical context.

Considerations

  • Toxicity Signs: Symptoms of digoxin toxicity may include nausea, vomiting, confusion, and visual disturbances.
  • Drug Interactions: Certain medications and conditions can affect digoxin levels and its effectiveness.

Conclusion

Regular monitoring through the digoxin test is crucial for patients on this medication to ensure safety and efficacy in treatment.

Risk assessment

Risk of Toxicity:

  • Digoxin has a narrow therapeutic index, meaning that the difference between a therapeutic and toxic dose is small.
  • Toxicity can lead to arrhythmias, gastrointestinal disturbances, and central nervous system symptoms (e.g., confusion or visual disturbances).

Patient Groups at Higher Risk:

      • Elderly patients (due to reduced renal clearance).
      • Patients with kidney disease or impaired renal function (digoxin is primarily excreted by the kidneys).
      • Patients on other medications that interact with digoxin (e.g., diuretics, antiarrhythmics).

Risk of Ineffectiveness:

        • Low digoxin levels may not adequately control heart failure or atrial fibrillation, increasing the risk of exacerbation of these conditions.
Ranges
  • Therapeutic Range:
    • 0.8–2.0 ng/mL.
    • Levels above 2.0 ng/mL increase the risk of toxicity.
Test result interpretation

Below Normal (<0.8 ng/mL):

    • May indicate subtherapeutic levels, which could result in ineffective treatment of heart conditions.

Normal (0.8–2.0 ng/mL):

    • Therapeutic range, where digoxin is likely effective without high risk of toxicity (but close monitoring may still be needed depending on symptoms).

Above Normal (>2.0 ng/mL):

    • Indicates risk of digoxin toxicity. Symptoms may include:
      • Nausea, vomiting, dizziness.
      • Visual disturbances (blurred vision, seeing halos).
      • Cardiac arrhythmias (e.g., bradycardia).
Sample types

Blood (Serum or plasma).

    • The sample is usually drawn from a vein.

Frequently Asked Question